Articles by Lynn D. Torbeck - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Lynn D. Torbeck

Compositing Samples and the Risk to Product Quality

Compositing samples is appropriate under certain circumstances but raises caveats on how and when it should be applied.
May 2, 2013

Compositing samples is appropriate under certain circumstances but raises caveats on how and when it should be applied.

Time to Revise ICH Q9

A change in terminology could emphasize patient protection.
Dec 2, 2012

A change in terminology could emphasize patient protection.

Tools in Waiting: Time for Evolutionary Operation

Real-time experimentation may offer continuous process improvement.
Oct 2, 2012

Real-time experimentation may offer continuous process improvement.

A Statistical Review of ICH Q10 Pharmaceutical Quality System

Applying the recommendations of ICH Q10 to statistical analysis can help prevent product recalls.
Aug 2, 2012

Applying the recommendations of ICH Q10 to statistical analysis can help prevent product recalls.

Placket–Burman Designs

Applying current principals to traditional factorial designs.
Jul 2, 2012

Applying current principals to traditional factorial designs.

Representative Sampling

Understanding the differences between convenience, target, and self-selected samples.
Apr 2, 2012

Understanding the differences between convenience, target, and self-selected samples.

Reducing Common Cause Variation

Where is the variability coming from and what have we done to minimize it?
Feb 2, 2012

Where is the variability coming from and what have we done to minimize it?

Out-of-Specification Sample-Size Confusion

Precedents set in the historic Barr case continue to raise questions over suitable sample-size criteria.
Dec 2, 2011

Precedents set in the historic Barr case continue to raise questions over suitable sample-size criteria.

OOS, OOT, OOC, and OOSC

Current GMPs demand full understandng of out-of-control concepts. This article contains bonus material.
Oct 2, 2011

Current GMPs demand full understandng of out-of-control concepts. This article contains bonus material.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here